Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Electronic Health Records | 85 | 2024 | 4775 | 5.750 |
Why?
|
Information Storage and Retrieval | 29 | 2024 | 822 | 4.820 |
Why?
|
Medical Records Systems, Computerized | 18 | 2018 | 1191 | 2.130 |
Why?
|
Software | 27 | 2024 | 4419 | 2.070 |
Why?
|
Algorithms | 51 | 2024 | 13981 | 2.030 |
Why?
|
Biomedical Research | 25 | 2024 | 3426 | 2.030 |
Why?
|
Medical Informatics | 14 | 2022 | 732 | 2.020 |
Why?
|
Natural Language Processing | 27 | 2023 | 1135 | 1.990 |
Why?
|
Data Mining | 7 | 2021 | 553 | 1.980 |
Why?
|
Intracranial Aneurysm | 18 | 2024 | 1276 | 1.530 |
Why?
|
Systems Integration | 13 | 2017 | 426 | 1.500 |
Why?
|
Aneurysm, Ruptured | 13 | 2021 | 460 | 1.480 |
Why?
|
Information Dissemination | 8 | 2022 | 1131 | 1.290 |
Why?
|
Medical Record Linkage | 8 | 2021 | 288 | 1.220 |
Why?
|
Computer Communication Networks | 6 | 2019 | 294 | 1.200 |
Why?
|
Informatics | 3 | 2022 | 73 | 1.090 |
Why?
|
User-Computer Interface | 7 | 2017 | 1403 | 0.960 |
Why?
|
Forms and Records Control | 3 | 2008 | 158 | 0.910 |
Why?
|
Medical Informatics Applications | 2 | 2018 | 178 | 0.880 |
Why?
|
Diagnosis | 2 | 2021 | 157 | 0.870 |
Why?
|
Databases as Topic | 4 | 2014 | 474 | 0.820 |
Why?
|
Inflammatory Bowel Diseases | 14 | 2019 | 2421 | 0.820 |
Why?
|
Databases, Factual | 14 | 2022 | 8035 | 0.790 |
Why?
|
Programming Languages | 5 | 2017 | 128 | 0.760 |
Why?
|
Biological Specimen Banks | 2 | 2022 | 783 | 0.740 |
Why?
|
Database Management Systems | 3 | 2014 | 258 | 0.710 |
Why?
|
Pattern Recognition, Automated | 4 | 2022 | 994 | 0.640 |
Why?
|
Genomics | 12 | 2023 | 5794 | 0.630 |
Why?
|
Medical Informatics Computing | 1 | 2018 | 24 | 0.630 |
Why?
|
Vocabulary, Controlled | 5 | 2018 | 167 | 0.620 |
Why?
|
ROC Curve | 8 | 2021 | 3568 | 0.590 |
Why?
|
Internet | 7 | 2018 | 3078 | 0.570 |
Why?
|
Humans | 188 | 2024 | 760621 | 0.570 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2024 | 1375 | 0.560 |
Why?
|
Colitis, Ulcerative | 7 | 2019 | 1919 | 0.530 |
Why?
|
Crohn Disease | 7 | 2019 | 2275 | 0.510 |
Why?
|
Disease | 1 | 2021 | 671 | 0.500 |
Why?
|
Current Procedural Terminology | 1 | 2015 | 90 | 0.500 |
Why?
|
Confidentiality | 5 | 2019 | 609 | 0.480 |
Why?
|
Cluster Analysis | 3 | 2023 | 2698 | 0.470 |
Why?
|
Learning | 1 | 2024 | 1739 | 0.470 |
Why?
|
Vulnerable Populations | 1 | 2019 | 696 | 0.440 |
Why?
|
International Classification of Diseases | 8 | 2019 | 894 | 0.430 |
Why?
|
Information Systems | 2 | 2014 | 398 | 0.430 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2024 | 1628 | 0.430 |
Why?
|
Phenotype | 20 | 2023 | 16546 | 0.410 |
Why?
|
Health Level Seven | 3 | 2018 | 35 | 0.410 |
Why?
|
Immunoglobulin G | 1 | 2024 | 4541 | 0.410 |
Why?
|
Hospitalization | 13 | 2022 | 10790 | 0.410 |
Why?
|
Continuity of Patient Care | 3 | 2021 | 1066 | 0.410 |
Why?
|
Computational Biology | 6 | 2013 | 3505 | 0.410 |
Why?
|
Registries | 9 | 2020 | 8469 | 0.410 |
Why?
|
Arthritis, Rheumatoid | 12 | 2018 | 3763 | 0.390 |
Why?
|
Anterior Cerebral Artery | 2 | 2021 | 50 | 0.370 |
Why?
|
Echocardiography | 2 | 2018 | 4981 | 0.360 |
Why?
|
Radiology Information Systems | 1 | 2015 | 528 | 0.360 |
Why?
|
Subarachnoid Hemorrhage | 4 | 2019 | 1032 | 0.350 |
Why?
|
Data Collection | 6 | 2023 | 3315 | 0.350 |
Why?
|
Unified Medical Language System | 4 | 2019 | 89 | 0.350 |
Why?
|
Basilar Artery | 2 | 2021 | 205 | 0.340 |
Why?
|
Data Interpretation, Statistical | 2 | 2019 | 2696 | 0.340 |
Why?
|
Adverse Drug Reaction Reporting Systems | 3 | 2011 | 488 | 0.330 |
Why?
|
Point-of-Care Systems | 1 | 2018 | 1204 | 0.330 |
Why?
|
Computer Security | 6 | 2021 | 260 | 0.330 |
Why?
|
Biology | 2 | 2022 | 290 | 0.330 |
Why?
|
Retrospective Studies | 30 | 2024 | 80372 | 0.320 |
Why?
|
Models, Statistical | 2 | 2021 | 5075 | 0.320 |
Why?
|
Medical Subject Headings | 1 | 2008 | 16 | 0.320 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2018 | 4357 | 0.320 |
Why?
|
Clostridium Infections | 2 | 2014 | 557 | 0.320 |
Why?
|
Community Networks | 2 | 2019 | 201 | 0.310 |
Why?
|
Artificial Intelligence | 5 | 2022 | 2557 | 0.300 |
Why?
|
Cohort Studies | 30 | 2024 | 41335 | 0.300 |
Why?
|
Search Engine | 1 | 2008 | 140 | 0.290 |
Why?
|
Electronics | 2 | 2023 | 315 | 0.280 |
Why?
|
Comparative Effectiveness Research | 3 | 2018 | 718 | 0.270 |
Why?
|
Image Processing, Computer-Assisted | 8 | 2021 | 8950 | 0.270 |
Why?
|
Circle of Willis | 3 | 2021 | 79 | 0.270 |
Why?
|
Severity of Illness Index | 4 | 2021 | 15840 | 0.270 |
Why?
|
Ventricular Function, Left | 1 | 2018 | 3880 | 0.250 |
Why?
|
Stroke Volume | 2 | 2019 | 5523 | 0.250 |
Why?
|
Middle Aged | 59 | 2024 | 220352 | 0.250 |
Why?
|
Comorbidity | 7 | 2020 | 10551 | 0.240 |
Why?
|
Male | 77 | 2024 | 359744 | 0.230 |
Why?
|
Cerebral Angiography | 5 | 2021 | 1274 | 0.230 |
Why?
|
Female | 83 | 2024 | 391270 | 0.230 |
Why?
|
Academic Medical Centers | 2 | 2012 | 2754 | 0.230 |
Why?
|
Patient-Centered Care | 1 | 2014 | 1416 | 0.230 |
Why?
|
Delivery of Health Care | 5 | 2023 | 5325 | 0.230 |
Why?
|
Terminology as Topic | 2 | 2008 | 1535 | 0.220 |
Why?
|
Logical Observation Identifiers Names and Codes | 2 | 2022 | 16 | 0.220 |
Why?
|
Adult | 54 | 2024 | 219994 | 0.220 |
Why?
|
Reproducibility of Results | 9 | 2022 | 20080 | 0.220 |
Why?
|
Hospital Information Systems | 6 | 2012 | 394 | 0.220 |
Why?
|
Aged | 45 | 2024 | 169152 | 0.220 |
Why?
|
Hypoglycemic Agents | 4 | 2024 | 3150 | 0.210 |
Why?
|
Agammaglobulinemia | 1 | 2024 | 173 | 0.210 |
Why?
|
Quality Indicators, Health Care | 1 | 2013 | 1824 | 0.210 |
Why?
|
United States | 25 | 2022 | 72461 | 0.210 |
Why?
|
Calcium | 8 | 2018 | 5725 | 0.210 |
Why?
|
Depressive Disorder, Major | 6 | 2020 | 4744 | 0.200 |
Why?
|
Gastrointestinal Agents | 2 | 2018 | 509 | 0.200 |
Why?
|
Prognosis | 10 | 2021 | 29658 | 0.200 |
Why?
|
Genome-Wide Association Study | 7 | 2022 | 12626 | 0.200 |
Why?
|
Pandemics | 5 | 2022 | 8624 | 0.200 |
Why?
|
Immunization, Passive | 1 | 2024 | 616 | 0.200 |
Why?
|
Case-Control Studies | 16 | 2021 | 22053 | 0.200 |
Why?
|
Diagnostic Imaging | 4 | 2022 | 3527 | 0.200 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8547 | 0.190 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2024 | 12293 | 0.190 |
Why?
|
Hypertension | 4 | 2023 | 8594 | 0.190 |
Why?
|
Risk Factors | 30 | 2024 | 74359 | 0.190 |
Why?
|
Receptors, Neurotransmitter | 3 | 1989 | 174 | 0.180 |
Why?
|
Middle Cerebral Artery | 1 | 2021 | 276 | 0.180 |
Why?
|
Vitamin D | 4 | 2015 | 3291 | 0.180 |
Why?
|
Logistic Models | 15 | 2020 | 13314 | 0.180 |
Why?
|
Massachusetts | 7 | 2023 | 8803 | 0.180 |
Why?
|
Risk Assessment | 10 | 2023 | 24123 | 0.170 |
Why?
|
Polymorphism, Single Nucleotide | 9 | 2022 | 15789 | 0.170 |
Why?
|
Personal Satisfaction | 1 | 2024 | 643 | 0.170 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 1 | 2023 | 334 | 0.160 |
Why?
|
Georgia | 1 | 2019 | 190 | 0.160 |
Why?
|
Color | 1 | 2020 | 298 | 0.160 |
Why?
|
Probability | 2 | 2021 | 2475 | 0.160 |
Why?
|
Diabetes Mellitus | 5 | 2022 | 5889 | 0.150 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 3 | 2023 | 3224 | 0.150 |
Why?
|
Hypertension, Pulmonary | 2 | 2020 | 1570 | 0.150 |
Why?
|
Antidepressive Agents | 4 | 2014 | 2890 | 0.150 |
Why?
|
Drug Therapy | 1 | 2021 | 504 | 0.150 |
Why?
|
Multivariate Analysis | 9 | 2020 | 12159 | 0.150 |
Why?
|
Heart Failure | 2 | 2019 | 11847 | 0.150 |
Why?
|
Age Factors | 7 | 2021 | 18416 | 0.140 |
Why?
|
Patients | 1 | 2024 | 906 | 0.140 |
Why?
|
Diagnostic Tests, Routine | 2 | 2021 | 786 | 0.140 |
Why?
|
Health Services Research | 2 | 2009 | 1810 | 0.140 |
Why?
|
Heroin Dependence | 1 | 2017 | 172 | 0.140 |
Why?
|
Metformin | 1 | 2024 | 912 | 0.140 |
Why?
|
International Normalized Ratio | 1 | 2018 | 386 | 0.140 |
Why?
|
Research Design | 3 | 2019 | 6180 | 0.140 |
Why?
|
Asthma | 4 | 2009 | 6172 | 0.140 |
Why?
|
Aged, 80 and over | 9 | 2024 | 58995 | 0.140 |
Why?
|
Magnesium | 2 | 2018 | 810 | 0.130 |
Why?
|
Insurance Claim Review | 1 | 2020 | 738 | 0.130 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2019 | 352 | 0.130 |
Why?
|
New England | 5 | 2022 | 1050 | 0.130 |
Why?
|
Hypercholesterolemia | 1 | 2023 | 1155 | 0.130 |
Why?
|
Professional-Patient Relations | 1 | 2021 | 726 | 0.130 |
Why?
|
Glutamates | 4 | 1989 | 391 | 0.130 |
Why?
|
TYK2 Kinase | 1 | 2015 | 37 | 0.120 |
Why?
|
Longitudinal Studies | 5 | 2024 | 14495 | 0.120 |
Why?
|
Quality Control | 1 | 2018 | 828 | 0.120 |
Why?
|
Brain | 8 | 2021 | 26951 | 0.120 |
Why?
|
Depressive Disorder | 3 | 2013 | 3726 | 0.120 |
Why?
|
Autoantibodies | 3 | 2013 | 2118 | 0.120 |
Why?
|
Genome | 1 | 2023 | 1739 | 0.120 |
Why?
|
Kainic Acid | 3 | 1989 | 199 | 0.120 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7475 | 0.120 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2017 | 2782 | 0.120 |
Why?
|
Arthralgia | 1 | 2018 | 461 | 0.120 |
Why?
|
C-Reactive Protein | 2 | 2018 | 3839 | 0.120 |
Why?
|
Mendelian Randomization Analysis | 1 | 2020 | 998 | 0.120 |
Why?
|
Minority Groups | 1 | 2021 | 1201 | 0.110 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 944 | 0.110 |
Why?
|
Genetic Pleiotropy | 1 | 2015 | 181 | 0.110 |
Why?
|
Vitamin D Deficiency | 2 | 2013 | 1379 | 0.110 |
Why?
|
Longevity | 1 | 2021 | 1050 | 0.110 |
Why?
|
Hypersensitivity | 1 | 2022 | 1155 | 0.110 |
Why?
|
Hypolipidemic Agents | 1 | 2018 | 626 | 0.110 |
Why?
|
Sensitivity and Specificity | 5 | 2021 | 14660 | 0.110 |
Why?
|
Organizations | 1 | 2014 | 171 | 0.110 |
Why?
|
Decision Support Systems, Clinical | 1 | 2022 | 1164 | 0.110 |
Why?
|
Blood Sedimentation | 1 | 2014 | 234 | 0.110 |
Why?
|
Respiration, Artificial | 2 | 2021 | 2622 | 0.110 |
Why?
|
Anticoagulants | 3 | 2020 | 4897 | 0.110 |
Why?
|
Respiratory Function Tests | 2 | 2007 | 1683 | 0.100 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2014 | 432 | 0.100 |
Why?
|
Computer Systems | 3 | 2011 | 470 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 9 | 2022 | 17790 | 0.100 |
Why?
|
Lipid Metabolism | 1 | 2020 | 1902 | 0.100 |
Why?
|
Corpus Striatum | 2 | 1989 | 1233 | 0.100 |
Why?
|
Cholangitis, Sclerosing | 1 | 2014 | 177 | 0.100 |
Why?
|
Organizational Innovation | 1 | 2015 | 536 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 5 | 2021 | 36290 | 0.100 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2019 | 3701 | 0.100 |
Why?
|
Anxiety Disorders | 2 | 2013 | 2714 | 0.100 |
Why?
|
Cholesterol, HDL | 1 | 2018 | 1817 | 0.100 |
Why?
|
Antibodies, Antinuclear | 1 | 2013 | 344 | 0.100 |
Why?
|
Prospective Studies | 9 | 2023 | 54303 | 0.100 |
Why?
|
Myelin Sheath | 1 | 2015 | 652 | 0.090 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2014 | 489 | 0.090 |
Why?
|
Sjogren's Syndrome | 1 | 2013 | 235 | 0.090 |
Why?
|
Health Insurance Portability and Accountability Act | 1 | 2011 | 105 | 0.090 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2015 | 452 | 0.090 |
Why?
|
Odds Ratio | 6 | 2020 | 9716 | 0.090 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2018 | 3334 | 0.090 |
Why?
|
Colorectal Neoplasms | 3 | 2016 | 6853 | 0.090 |
Why?
|
Obesity, Morbid | 1 | 2021 | 1287 | 0.090 |
Why?
|
Parturition | 1 | 2014 | 446 | 0.090 |
Why?
|
Iron | 1 | 2019 | 1786 | 0.090 |
Why?
|
Patient Selection | 1 | 2003 | 4283 | 0.090 |
Why?
|
Bipolar Disorder | 3 | 2018 | 5078 | 0.090 |
Why?
|
Paroxetine | 1 | 2011 | 182 | 0.090 |
Why?
|
Lipoproteins, LDL | 1 | 2013 | 641 | 0.090 |
Why?
|
Drug Therapy, Combination | 2 | 2020 | 6498 | 0.090 |
Why?
|
Hospital Shared Services | 1 | 2009 | 16 | 0.090 |
Why?
|
Warfarin | 1 | 2018 | 1518 | 0.080 |
Why?
|
Delirium | 1 | 2021 | 1663 | 0.080 |
Why?
|
Area Under Curve | 3 | 2019 | 1636 | 0.080 |
Why?
|
Limbic System | 1 | 2012 | 419 | 0.080 |
Why?
|
Angiography, Digital Subtraction | 2 | 2021 | 334 | 0.080 |
Why?
|
Telemedicine | 2 | 2019 | 3018 | 0.080 |
Why?
|
Pravastatin | 1 | 2011 | 393 | 0.080 |
Why?
|
Decision Support Techniques | 2 | 2020 | 2001 | 0.080 |
Why?
|
Immunologic Factors | 2 | 2015 | 1588 | 0.080 |
Why?
|
Aspartic Acid | 2 | 1989 | 576 | 0.080 |
Why?
|
Lipoproteins | 1 | 2013 | 882 | 0.080 |
Why?
|
Time Factors | 5 | 2021 | 40165 | 0.080 |
Why?
|
Serum Albumin | 1 | 2012 | 674 | 0.080 |
Why?
|
Suicide | 1 | 2020 | 1599 | 0.080 |
Why?
|
Follow-Up Studies | 8 | 2019 | 39261 | 0.080 |
Why?
|
Models, Theoretical | 2 | 2018 | 3562 | 0.080 |
Why?
|
Infant, Newborn | 8 | 2021 | 26181 | 0.080 |
Why?
|
Bayes Theorem | 3 | 2022 | 2326 | 0.080 |
Why?
|
Hypothyroidism | 1 | 2013 | 665 | 0.070 |
Why?
|
Risk | 5 | 2020 | 9631 | 0.070 |
Why?
|
Intensive Care Units | 1 | 2021 | 3736 | 0.070 |
Why?
|
Thromboembolism | 1 | 2014 | 1017 | 0.070 |
Why?
|
Genotype | 5 | 2015 | 12960 | 0.070 |
Why?
|
Delivery, Obstetric | 1 | 2014 | 932 | 0.070 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2012 | 599 | 0.070 |
Why?
|
Incidence | 7 | 2024 | 21392 | 0.070 |
Why?
|
Autoimmunity | 1 | 2015 | 1370 | 0.070 |
Why?
|
Blood Pressure | 2 | 2023 | 8525 | 0.070 |
Why?
|
Colectomy | 1 | 2012 | 692 | 0.070 |
Why?
|
Accidental Falls | 1 | 2014 | 1056 | 0.070 |
Why?
|
Hippocampus | 3 | 1989 | 3738 | 0.070 |
Why?
|
Young Adult | 10 | 2021 | 58741 | 0.070 |
Why?
|
Myoblasts, Skeletal | 1 | 2006 | 75 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2016 | 1796 | 0.070 |
Why?
|
Goals | 1 | 2011 | 708 | 0.070 |
Why?
|
Colonoscopy | 1 | 2014 | 1387 | 0.070 |
Why?
|
Creatinine | 1 | 2012 | 1903 | 0.070 |
Why?
|
Chi-Square Distribution | 2 | 2014 | 3465 | 0.070 |
Why?
|
Hemoglobins | 1 | 2012 | 1521 | 0.060 |
Why?
|
Proportional Hazards Models | 3 | 2022 | 12531 | 0.060 |
Why?
|
Cesarean Section | 1 | 2014 | 1385 | 0.060 |
Why?
|
Smoking | 3 | 2020 | 9073 | 0.060 |
Why?
|
Smoking Cessation | 1 | 2017 | 2064 | 0.060 |
Why?
|
Dyslipidemias | 1 | 2013 | 895 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2018 | 1652 | 0.060 |
Why?
|
Information Management | 1 | 2006 | 100 | 0.060 |
Why?
|
Psychotic Disorders | 1 | 2020 | 3193 | 0.060 |
Why?
|
Child, Preschool | 9 | 2021 | 42063 | 0.060 |
Why?
|
Genetic Testing | 1 | 2018 | 3531 | 0.060 |
Why?
|
Brain Injuries | 1 | 2017 | 2044 | 0.060 |
Why?
|
DNA Copy Number Variations | 1 | 2014 | 2013 | 0.060 |
Why?
|
Quisqualic Acid | 3 | 1989 | 35 | 0.060 |
Why?
|
Genetic Association Studies | 1 | 2014 | 2717 | 0.060 |
Why?
|
Body Mass Index | 5 | 2021 | 12914 | 0.060 |
Why?
|
Amino Acids | 2 | 1987 | 1714 | 0.060 |
Why?
|
Referral and Consultation | 1 | 1998 | 3598 | 0.060 |
Why?
|
Health Care Surveys | 1 | 2012 | 2435 | 0.060 |
Why?
|
Oxadiazoles | 3 | 1989 | 94 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2017 | 4013 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2024 | 65017 | 0.060 |
Why?
|
Infant | 7 | 2021 | 36060 | 0.060 |
Why?
|
Postoperative Complications | 2 | 2020 | 15697 | 0.060 |
Why?
|
Models, Genetic | 1 | 2014 | 3442 | 0.060 |
Why?
|
Obesity | 3 | 2022 | 12922 | 0.060 |
Why?
|
Weight Gain | 1 | 2014 | 2347 | 0.060 |
Why?
|
Boston | 5 | 2016 | 9280 | 0.060 |
Why?
|
Child | 11 | 2022 | 79806 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2022 | 5209 | 0.050 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2006 | 542 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 3 | 2021 | 4048 | 0.050 |
Why?
|
Arrhythmias, Cardiac | 1 | 2013 | 2255 | 0.050 |
Why?
|
Predictive Value of Tests | 3 | 2017 | 15289 | 0.050 |
Why?
|
Lipids | 1 | 2013 | 3336 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 2282 | 0.050 |
Why?
|
Forecasting | 1 | 2011 | 2932 | 0.050 |
Why?
|
Quality Improvement | 2 | 2015 | 3836 | 0.050 |
Why?
|
Sulfonylurea Compounds | 1 | 2023 | 221 | 0.050 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2014 | 2496 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2014 | 2477 | 0.050 |
Why?
|
Brain Mapping | 1 | 2017 | 6568 | 0.050 |
Why?
|
Calcium Channels | 3 | 1990 | 619 | 0.050 |
Why?
|
Diffusion Tensor Imaging | 1 | 2012 | 2385 | 0.050 |
Why?
|
Knowledge Bases | 1 | 2022 | 98 | 0.050 |
Why?
|
Comoros | 1 | 2020 | 12 | 0.050 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2006 | 841 | 0.050 |
Why?
|
Adolescent | 9 | 2021 | 87810 | 0.050 |
Why?
|
Disease Progression | 4 | 2023 | 13502 | 0.050 |
Why?
|
Health Policy | 1 | 2013 | 2677 | 0.050 |
Why?
|
Cholesterol, LDL | 2 | 2023 | 2420 | 0.050 |
Why?
|
Computer Graphics | 1 | 2003 | 341 | 0.050 |
Why?
|
Prevalence | 4 | 2021 | 15687 | 0.050 |
Why?
|
Propensity Score | 2 | 2018 | 1928 | 0.040 |
Why?
|
Patient Acceptance of Health Care | 1 | 2014 | 3164 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5397 | 0.040 |
Why?
|
Neurons | 3 | 1988 | 9426 | 0.040 |
Why?
|
Privacy | 1 | 2022 | 233 | 0.040 |
Why?
|
Mental Disorders | 1 | 2020 | 6796 | 0.040 |
Why?
|
National Human Genome Research Institute (U.S.) | 1 | 2019 | 22 | 0.040 |
Why?
|
Ethics Committees, Research | 1 | 2021 | 196 | 0.040 |
Why?
|
Peptides, Cyclic | 2 | 2013 | 392 | 0.040 |
Why?
|
Pituitary Gland, Anterior | 2 | 1990 | 142 | 0.040 |
Why?
|
Electrocardiography | 1 | 2013 | 6414 | 0.040 |
Why?
|
Aortic Aneurysm | 1 | 2024 | 648 | 0.040 |
Why?
|
Automation | 1 | 2021 | 580 | 0.040 |
Why?
|
Psychiatry | 1 | 2011 | 1689 | 0.040 |
Why?
|
Vital Capacity | 1 | 2021 | 965 | 0.040 |
Why?
|
Colestipol | 1 | 2018 | 11 | 0.040 |
Why?
|
Multiple Sclerosis | 1 | 2013 | 3204 | 0.040 |
Why?
|
Cholestyramine Resin | 1 | 2018 | 25 | 0.040 |
Why?
|
Cooperative Behavior | 1 | 2006 | 1500 | 0.040 |
Why?
|
Fibric Acids | 1 | 2018 | 28 | 0.040 |
Why?
|
Psychomotor Agitation | 1 | 2020 | 305 | 0.040 |
Why?
|
N-Methylaspartate | 2 | 1989 | 231 | 0.040 |
Why?
|
Rupture, Spontaneous | 1 | 2018 | 356 | 0.040 |
Why?
|
Peer Review, Research | 1 | 2021 | 340 | 0.040 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2020 | 404 | 0.040 |
Why?
|
Sex Factors | 3 | 2020 | 10547 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2021 | 791 | 0.040 |
Why?
|
Models, Biological | 1 | 2013 | 9467 | 0.040 |
Why?
|
Drug Interactions | 2 | 2012 | 1428 | 0.040 |
Why?
|
Lipase | 1 | 2019 | 324 | 0.040 |
Why?
|
Insurance Claim Reporting | 1 | 2017 | 165 | 0.040 |
Why?
|
Cross-Sectional Studies | 5 | 2018 | 25942 | 0.030 |
Why?
|
Cardiovascular Diseases | 2 | 2020 | 15757 | 0.030 |
Why?
|
Workflow | 1 | 2021 | 852 | 0.030 |
Why?
|
Blood Glucose | 1 | 2011 | 6381 | 0.030 |
Why?
|
Government Regulation | 1 | 2021 | 525 | 0.030 |
Why?
|
Forced Expiratory Volume | 1 | 2021 | 1809 | 0.030 |
Why?
|
Documentation | 1 | 2022 | 893 | 0.030 |
Why?
|
Ferritins | 1 | 2019 | 597 | 0.030 |
Why?
|
Fatigue | 1 | 2023 | 1544 | 0.030 |
Why?
|
Organ Size | 1 | 2020 | 2254 | 0.030 |
Why?
|
Methods | 1 | 1996 | 1074 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2015 | 6659 | 0.030 |
Why?
|
Oligonucleotides | 1 | 2018 | 588 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 2022 | 1784 | 0.030 |
Why?
|
Neoplasms | 2 | 2014 | 22072 | 0.030 |
Why?
|
Drug Utilization | 1 | 2020 | 1195 | 0.030 |
Why?
|
Nortriptyline | 1 | 2014 | 79 | 0.030 |
Why?
|
Amitriptyline | 1 | 2014 | 112 | 0.030 |
Why?
|
Rectal Fistula | 1 | 2014 | 75 | 0.030 |
Why?
|
Atlases as Topic | 1 | 2015 | 241 | 0.030 |
Why?
|
Skull | 1 | 2018 | 815 | 0.030 |
Why?
|
Dwarfism | 1 | 1975 | 137 | 0.030 |
Why?
|
Morbidity | 1 | 2019 | 1765 | 0.030 |
Why?
|
Nitrendipine | 2 | 1990 | 12 | 0.030 |
Why?
|
Mass Screening | 1 | 2009 | 5423 | 0.030 |
Why?
|
Medicare | 2 | 2022 | 6786 | 0.030 |
Why?
|
Pharmacies | 1 | 2015 | 164 | 0.030 |
Why?
|
Publishing | 1 | 2021 | 836 | 0.030 |
Why?
|
Glutamic Acid | 2 | 1989 | 1167 | 0.030 |
Why?
|
Genetic Research | 1 | 2014 | 172 | 0.030 |
Why?
|
Hospitals, General | 1 | 1998 | 795 | 0.030 |
Why?
|
England | 1 | 2014 | 526 | 0.030 |
Why?
|
Patient Discharge | 1 | 2006 | 3476 | 0.030 |
Why?
|
Medical Audit | 1 | 2014 | 452 | 0.030 |
Why?
|
Cost of Illness | 1 | 2022 | 1940 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2018 | 858 | 0.030 |
Why?
|
Thyroiditis | 1 | 2013 | 86 | 0.030 |
Why?
|
Patient Access to Records | 1 | 2013 | 119 | 0.030 |
Why?
|
Bupropion | 1 | 2014 | 304 | 0.030 |
Why?
|
Fornix, Brain | 1 | 2012 | 71 | 0.030 |
Why?
|
Sex Ratio | 1 | 2012 | 107 | 0.020 |
Why?
|
Transglutaminases | 1 | 2013 | 197 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1869 | 0.020 |
Why?
|
Heart Diseases | 1 | 2005 | 2809 | 0.020 |
Why?
|
Feasibility Studies | 2 | 2012 | 5201 | 0.020 |
Why?
|
Seroepidemiologic Studies | 1 | 2013 | 394 | 0.020 |
Why?
|
Citalopram | 1 | 2014 | 402 | 0.020 |
Why?
|
Biological Products | 1 | 2020 | 916 | 0.020 |
Why?
|
Iodide Peroxidase | 1 | 2013 | 294 | 0.020 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2015 | 377 | 0.020 |
Why?
|
Organizational Policy | 1 | 2013 | 429 | 0.020 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2014 | 506 | 0.020 |
Why?
|
Sample Size | 1 | 2014 | 840 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2018 | 1725 | 0.020 |
Why?
|
Attention | 1 | 2021 | 2387 | 0.020 |
Why?
|
Dihydropyridines | 2 | 1988 | 68 | 0.020 |
Why?
|
Mother-Child Relations | 1 | 2014 | 491 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2015 | 782 | 0.020 |
Why?
|
Hospitals, University | 1 | 2012 | 568 | 0.020 |
Why?
|
Cells, Cultured | 5 | 2006 | 18957 | 0.020 |
Why?
|
6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 1989 | 55 | 0.020 |
Why?
|
Survival Analysis | 1 | 2022 | 10182 | 0.020 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2020 | 1459 | 0.020 |
Why?
|
Inositol 1,4,5-Trisphosphate | 1 | 1989 | 110 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 934 | 0.020 |
Why?
|
Digestive System Surgical Procedures | 1 | 2014 | 575 | 0.020 |
Why?
|
Ibotenic Acid | 1 | 1988 | 59 | 0.020 |
Why?
|
Homeostasis | 2 | 2011 | 3306 | 0.020 |
Why?
|
Inositol Phosphates | 1 | 1989 | 176 | 0.020 |
Why?
|
Exons | 1 | 2015 | 2388 | 0.020 |
Why?
|
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 1988 | 70 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 1602 | 0.020 |
Why?
|
Anisotropy | 1 | 2012 | 1278 | 0.020 |
Why?
|
GTP-Binding Proteins | 1 | 2013 | 951 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2009 | 11891 | 0.020 |
Why?
|
Methotrexate | 1 | 2015 | 1719 | 0.020 |
Why?
|
Dibenzocycloheptenes | 1 | 1987 | 27 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 3061 | 0.020 |
Why?
|
Ion Channel Gating | 1 | 1990 | 436 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2015 | 1489 | 0.020 |
Why?
|
Follicle Stimulating Hormone | 1 | 1990 | 725 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3928 | 0.020 |
Why?
|
Receptors, Glutamate | 1 | 1988 | 229 | 0.020 |
Why?
|
Potassium | 2 | 1989 | 1313 | 0.020 |
Why?
|
Luteinizing Hormone | 1 | 1990 | 820 | 0.020 |
Why?
|
Animals | 9 | 2007 | 167963 | 0.020 |
Why?
|
Receptors, AMPA | 1 | 1989 | 323 | 0.020 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2014 | 867 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 4713 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2012 | 805 | 0.020 |
Why?
|
Quinoxalines | 1 | 1989 | 297 | 0.020 |
Why?
|
Virginia | 1 | 2007 | 116 | 0.020 |
Why?
|
Indiana | 1 | 2007 | 93 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 1990 | 694 | 0.020 |
Why?
|
Birth Weight | 1 | 1975 | 2097 | 0.020 |
Why?
|
Bone Morphogenetic Protein Receptors, Type I | 1 | 2006 | 97 | 0.020 |
Why?
|
Bone Morphogenetic Protein 4 | 1 | 2006 | 161 | 0.020 |
Why?
|
Remission Induction | 1 | 2012 | 2392 | 0.020 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2012 | 952 | 0.020 |
Why?
|
Gonadotropin-Releasing Hormone | 2 | 1990 | 1153 | 0.020 |
Why?
|
Gyrus Cinguli | 1 | 2012 | 1114 | 0.020 |
Why?
|
Anxiety | 1 | 2020 | 4538 | 0.020 |
Why?
|
Permeability | 1 | 1987 | 719 | 0.020 |
Why?
|
Peptides | 1 | 2018 | 4354 | 0.020 |
Why?
|
Genetic Loci | 1 | 2015 | 2618 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 4166 | 0.020 |
Why?
|
Pennsylvania | 1 | 2007 | 615 | 0.020 |
Why?
|
Genome, Human | 1 | 2018 | 4417 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2009 | 1180 | 0.010 |
Why?
|
Patient Participation | 1 | 2013 | 1439 | 0.010 |
Why?
|
Alleles | 1 | 2015 | 6898 | 0.010 |
Why?
|
Glycine | 1 | 1987 | 662 | 0.010 |
Why?
|
Kinetics | 2 | 1988 | 6377 | 0.010 |
Why?
|
Gene Frequency | 1 | 2011 | 3615 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6544 | 0.010 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 1989 | 893 | 0.010 |
Why?
|
Sodium | 1 | 1989 | 1594 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8056 | 0.010 |
Why?
|
Drug Monitoring | 1 | 2009 | 965 | 0.010 |
Why?
|
Rats, Inbred Strains | 3 | 1990 | 2094 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 1988 | 1674 | 0.010 |
Why?
|
Diabetes Complications | 1 | 2009 | 1341 | 0.010 |
Why?
|
United States Food and Drug Administration | 1 | 2011 | 1677 | 0.010 |
Why?
|
Pregnancy | 2 | 2014 | 29749 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2012 | 6015 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2019 | 7850 | 0.010 |
Why?
|
Mice | 5 | 1989 | 81208 | 0.010 |
Why?
|
Mice, Inbred C57BL | 3 | 1989 | 22023 | 0.010 |
Why?
|
Quality Assurance, Health Care | 1 | 2012 | 2176 | 0.010 |
Why?
|
Ion Channels | 1 | 1986 | 1043 | 0.010 |
Why?
|
Research | 1 | 2010 | 1974 | 0.010 |
Why?
|
Societies, Medical | 1 | 2013 | 3905 | 0.010 |
Why?
|
Primary Health Care | 1 | 1998 | 4647 | 0.010 |
Why?
|
Computer Simulation | 1 | 2014 | 6218 | 0.010 |
Why?
|
Genetic Variation | 1 | 2015 | 6551 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2011 | 2781 | 0.010 |
Why?
|
Patient Readmission | 1 | 2014 | 3323 | 0.010 |
Why?
|
Survival Rate | 1 | 2014 | 12808 | 0.010 |
Why?
|
Synapses | 1 | 1989 | 1757 | 0.010 |
Why?
|
Pilot Projects | 1 | 2012 | 8555 | 0.010 |
Why?
|
Fetus | 1 | 2006 | 1859 | 0.010 |
Why?
|
Inflammation | 1 | 2018 | 10756 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 1987 | 2825 | 0.010 |
Why?
|
Software Design | 1 | 1998 | 171 | 0.010 |
Why?
|
Decision Making, Computer-Assisted | 1 | 1998 | 146 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2011 | 7806 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23376 | 0.010 |
Why?
|
Reminder Systems | 1 | 1998 | 387 | 0.010 |
Why?
|
Pyridines | 1 | 1986 | 2879 | 0.010 |
Why?
|
Depression | 1 | 2013 | 8044 | 0.010 |
Why?
|
Consanguinity | 1 | 1975 | 456 | 0.010 |
Why?
|
Rats | 4 | 1990 | 23711 | 0.010 |
Why?
|
omega-Conotoxin GVIA | 1 | 1990 | 19 | 0.010 |
Why?
|
Secretory Rate | 1 | 1990 | 81 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2006 | 10446 | 0.010 |
Why?
|
Syndrome | 1 | 1975 | 3280 | 0.000 |
Why?
|
Receptors, Amino Acid | 1 | 1987 | 30 | 0.000 |
Why?
|
Phencyclidine | 1 | 1987 | 60 | 0.000 |
Why?
|
Convulsants | 1 | 1987 | 70 | 0.000 |
Why?
|
Dizocilpine Maleate | 1 | 1987 | 172 | 0.000 |
Why?
|
Abnormalities, Multiple | 1 | 1975 | 1415 | 0.000 |
Why?
|
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 1986 | 34 | 0.000 |
Why?
|
Membrane Potentials | 1 | 1990 | 1095 | 0.000 |
Why?
|
Pedigree | 1 | 1975 | 4578 | 0.000 |
Why?
|
Cytosol | 1 | 1986 | 887 | 0.000 |
Why?
|
Organ Specificity | 1 | 1986 | 1955 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1975 | 12965 | 0.000 |
Why?
|
Cell Membrane | 1 | 1987 | 3682 | 0.000 |
Why?
|